8-K
false 0000701985 0000701985 2023-12-06 2023-12-06

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 6, 2023

 

 

Bath & Body Works, Inc.

(Exact name of registrant as specified in charter)

 

 

Delaware

(State or other jurisdiction

of incorporation)

 

1-8344   31-1029810
(Commission
File Number)
 

(IRS Employer

Identification No.)

 

Three Limited Parkway
Columbus, OH
  43230
(Address of principal executive offices)   (Zip Code)

(614) 415-7000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.50 Par Value   BBWI   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 7.01. Regulation FD Disclosure.

On December 6, 2023, members of Bath & Body Works, Inc.’s (the “Company”) executive team participated in a previously announced webcast at the Morgan Stanley Global Consumer & Retail Conference at 8:45 a.m. Eastern Time. During the webcast, the Company reaffirmed the Company’s previously announced fourth quarter 2023 net sales guidance range of a decline of 1% to 5% and its previously announced full-year 2023 net sales guidance range of a decline of 2.5% to 4%. A replay of the audio webcast of the presentation is available through the Investor Relations portion of the Company’s website at http://investors.bbwinc.com.

The information in this Item 7.01 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 7.01 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    BATH & BODY WORKS, INC.
Date: December 6, 2023     By:  

/s/ Eva C. Boratto

      Name:   Eva C. Boratto
      Title:   Chief Financial Officer